Status:
TERMINATED
LACE+ and MRS Score Readmission Rate Assessment
Lead Sponsor:
Tabula Rasa HealthCare
Conditions:
Hospitalism
Eligibility:
All Genders
18-88 years
Brief Summary
A study to demonstrate that the LACE+ score in non-inferior to the medication risk score when predicting 30-day readmission post hospital discharge.
Detailed Description
The objective of this study is evaluate a program that provides transition of care services to a local Tucson hospital involving activities designed to reduce 30 day post hospital discharge readmissio...
Eligibility Criteria
Inclusion
- Those referred to receive transition of care services between January 2018 to December 2019 and were discharged on 10 or more medications.
Exclusion
- 89 years or older
Key Trial Info
Start Date :
July 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04365673
Start Date
July 7 2020
End Date
March 1 2021
Last Update
March 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tabula Rasa HealthCare
Tucson, Arizona, United States, 85701